-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, BgdkB5+R5pITowdt3mwPNQ6RMZsrWrma1l2KBcNRh8pE9cSb7//tDU8tAL8dI3rz RnCOcp6ZzF5oS7TpXHa3fA== 0001181431-05-041858.txt : 20050725 0001181431-05-041858.hdr.sgml : 20050725 20050725182616 ACCESSION NUMBER: 0001181431-05-041858 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050721 FILED AS OF DATE: 20050725 DATE AS OF CHANGE: 20050725 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HOLLIS EDEN PHARMACEUTICALS INC /DE/ CENTRAL INDEX KEY: 0000899394 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133697002 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4435 EASTGATE MALL STREET 2: SUITE 400 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-587-9333 MAIL ADDRESS: STREET 1: 4435 EASTGATE MALL STREET 2: SUITE 400 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: INITIAL ACQUISITION CORP DATE OF NAME CHANGE: 19930329 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WEBER ROBERT W CENTRAL INDEX KEY: 0001239653 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-24672 FILM NUMBER: 05972410 MAIL ADDRESS: STREET 1: C/O HOLLIS-EDEN PHARMACEUTICALS STREET 2: 4435 EASTGATE MALL STE.400 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 rrd85325.xml OPTION SALE 07/21/05 X0202 4 2005-07-21 0 0000899394 HOLLIS EDEN PHARMACEUTICALS INC /DE/ HEPH 0001239653 WEBER ROBERT W 4435 EASTGATE MALL, SUITE 400 SAN DIEGO CA 92121 0 1 0 1 Chief Accounting Officer and VP Controller Common Stock 2005-07-21 4 M 0 1600 2.25 A 18652 D Common Stock 2005-07-21 4 S 0 1600 8.25 D 17052 D Common Stock 7000 I By children Stock Option (Right to Buy) 2.25 2005-07-21 4 M 0 1600 0 D 2006-03-15 Common Stock 1600 22200 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 21, 2004 The option vested and became exercisable over a period of three years, and was fully exercisable beginning April 1, 1999. Robert W. Weber 2005-07-25 -----END PRIVACY-ENHANCED MESSAGE-----